Appili Therapeutics Reports Fiscal Year 2023 Financial and O

Executed US$7.3M initial contract with U.S. Air Force Academy for ATI-1701

Upcoming PDUFA date of September 23, 2023 for ATI-1501

Related Keywords

United States , Canada , Canadian , Don Cilla , Contract Drug Manufacturing Organization , Appili Therapeutics Inc , Trademark Office , International Accounting Standard Board , Company Or Appili , Us Department Of Defense , Defense Threat Reduction Agency , Long Zone Holdings , Us Air Force Academy , Appili Therapeutics , Force Academy , Chief Executive Officer , Biodefense Vaccine Candidate , Nsecured Funding , Orphan Drug Designation , Patent Coverage , United States Patent , Infection Using , Chartered Professional Accountants , Canada Handbook , Long Zone , Common Shares ,